Abstract
BackgroundNusinersen has been used to treat spinal muscular atrophy type 1 (SMA1) in the UK since 2017. While initial trials showed neuromuscular benefit from treating SMA1, there is little information...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have